First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Mitchell
News Release
Purdue Pharma and DOJ Reach Opioid Settlement
Purdue Pharma and the Department of Justice (DOJ) have reached a settlement on Purdue's involvement in the opioid crisis.
Workers' Comp
Case Study
Phoenix Rising: Changing Course After Tragedy
As a flight paramedic in Phoenix, AZ, Derek Boehm’s job was to rescue those whose lives were on the line in emergency situations.
Workers' Comp
News Release
Genex chronicles flight paramedic's rise from a deadly helicopter crash
‘Phoenix Rising’ video offers inside look at the important link between specialized case manager intervention and injured employee recovery
Mitchell
News Release
GSK Consumer Healthcare Requests Halt of Excedrin Sale & Teva Pharmaceuticals Releases Generic Truvada
Excedrin Lots On October 7, 2020, GSK Consumer Healthcare requested retailers halt sales of certain Excedrin lots.
Mitchell
News Release
Rising Opioid Abuse, Increasing Acceptance of Marijuana and COVID-19 Continue to Shape Pharmacy Programs
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
Clinical Cannabis Considerations
It seems there is always something new to say when it comes to the hot topic of medical marijuana or “cannabis,” as it’s commo